Science Current Events | Science News | Brightsurf.com
 
corner top left block corner top right

Breaking the 'mucus barrier' with a new drug delivery system

August 20, 2008

Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis, the research noted in a presentation scheduled for the 236th National Meeting of the American Chemical Society.

"We studied the properties of disease-causing viruses that evolved to infect mucosal surfaces to engineer a coating that enables our drug delivery particles to penetrate mucus layers in minutes. In our new work, we have improved the coatings considerably to allow faster penetration for a wider array of particle sizes," says lead presenter Samuel K. Lai, Ph.D.

Mucus, the slippery secretion lining the lung airways, surface of the eye, gastrointestinal tract, and female reproductive tract, may seem delicate. But it is a tenacious barrier, effectively keeping out most pathogens and limiting infections.

"Mucus has evolved to be a highly efficient barrier," says Justin Hanes, professor of chemical & biomolecular engineering at Johns Hopkins University, the lead investigator of the study. "For example, we constantly inhale particles into our lungs, but they typically stick to mucus rather than penetrate it. Particles that stick are removed rapidly from the lungs on a mucus 'conveyor belt,' and are swallowed and sterilized in the gut. Mucus barriers protect us from constant infection, as well as everyday things like the millions of particles in the black cloud emitted from a bus when it takes off from a stop."

Unfortunately, mucus also prevents the passage of many beneficial drugs. And when the mucus gets thicker - most notably in diseases like chronic sinusitis, cystic fibrosis and chronic obstructive pulmonary disorder - drug treatment of the lungs and other mucus-lined areas becomes more difficult.

Lai explained that coating drug-loaded nanoparticles with an inexpensive polymer material allows particles to pass through the mucus linings. With this mucus-penetrating mechanism, drugs could be delivered locally and with enhanced durations to treat diseases at mucosal surfaces. In collaboration with Richard Cone, professor of biophysics at Johns Hopkins, the work also opens the door to more targeted drug delivery - including improved chemotherapy for cervical and lung cancer patients.

For inspiration in their quest to breech mucus, Hanes and colleagues took a lesson from Mother Nature - specifically viruses capable of infecting mucosal surfaces. Some of these viruses were able to pass through the dense, net-like mesh of mucus as if it were water.

The researchers found that the spaces between the "threads" of the mucus mesh were much larger than previously thought, providing an opportunity for drug particles that do not adhere to mucus to pass through and avoid rapid clearance .

"If a particle is small enough and not adhesive, then it can get through the mucus net - that's how some viruses penetrate mucus barriers," says Hanes.

The team found that a polymer known as polyethylene glycol, or PEG, could coat individual drug particles and imbue them with the same properties as these mucus-breeching viruses. "PEG is one of the most widely used polymers for therapeutic applications," Lai explains. It's an FDA approved polymer that's been in use in humans for over 25 years - it's known to be very safe."

By encapsulating drugs in mucus-penetrating particles, drug companies could expand the realm of treatment options for many diseases. "For example, cervical cancer patients could locally apply chemo drugs inside mucus-penetrating particles, which would then deliver the drug locally in the female reproductive tract at efficient concentrations over prolonged periods of time, instead of delivering it everywhere else in the body. That could drastically reduce the side effects as well as prolong the presence of drugs at the target site," says Lai.

And in the case of patients with cystic fibrosis -which causes thick mucus buildup in the lungs - mucus-penetrating drugs could create more effective therapies to fight the disease. This could improve the quality of life for 70,000 cystic fibrosis sufferers worldwide.

"Eventually, we seek to engineer systems where a drug could be delivered to a specific tissue or set of cells anywhere in the body - we want to make that possible."

American Chemical Society




Drug Delivery Systems, Third Edition (Pharmacology & Toxicology: Basic & Clinical Aspects S.)

Drug Delivery Systems, Third Edition (Pharmacology & Toxicology: Basic & Clinical Aspects S.)
by Vasant V. Ranade (Author), John B. Cannon (Author)


Drug delivery technologies represent a vast and vital area of research and development in pharmaceutics. The demand for innovative drug delivery systems continues to grow, and this growth drives a variety of new developments. Building on the foundation provided by the second edition, Drug Delivery Systems, Third Edition covers the latest in research, development, and regulations in industry and academia. The third edition of this popular book provides a comprehensive review of the latest research and development on drug delivery systems (including liposomal, transmucosal, transdermal, oral, polymeric, and monoclonal antibody directed delivery); it also contains a new chapter on nanoscience and technology for drug delivery along with cutting-edge business intelligence and strategies....

Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems

Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems
by Loyd V. Allen (Editor), Nicholas G. Popovich (Editor), Howard C. Ansel (Editor)


Long established as a core text for pharmaceutics courses, this book is the most comprehensive source on pharmaceutical dosage forms and drug delivery systems. Content coincides with the CAPE, APhA, and NAPLEX® competencies. This edition includes updated drug information and has an increased focus on physical pharmacy. Coverage incorporates all new dosage forms on the market as well as those in the current US Pharmacopoeia-National Formulary. Updated photos are included. An "Applying the Principles and Concepts" section at the end of each chapter provides activities for the application of the material. A companion website includes the fully searchable text and a quiz bank with more than 200 questions written in NAPLEX® format.

Ophthalmic Drug Delivery Systems, Second Edition (Drugs and the Pharmaceutical Sciences)

Ophthalmic Drug Delivery Systems, Second Edition (Drugs and the Pharmaceutical Sciences)
by Ashim K. Mitra (Editor)


Extensively revised and updated, this second edition compares conventional and innovative drug delivery systems. The book covers significant ophthalmic advances and breakthroughs in gene therapy, ocular microdialysis, vitreous drug disposition modelling, and receptor/transporter targeted drug delivery. It examines procedures in pharmacokinetic/pharmacodynamic modeling for the determination of appropriate dosing regimens, covers new developments in animal modeling, and discusses current regulations governing patenting, commercial product release, and human testing. This in-depth reference lays the groundwork for overcoming constraints on the delivery of ophthalmic drugs.

Pharmaceutical Dosage Forms and Drug Delivery, Second Edition (Pharmacy Education Series)

Pharmaceutical Dosage Forms and Drug Delivery, Second Edition (Pharmacy Education Series)
by Ram I. Mahato (Author), Ajit S. Narang (Author)


Completely revised and updated, this second edition of Pharmaceutical Dosage Forms and Drug Delivery elucidates the basic principles of pharmaceutics, dosage form design, and drug delivery. The authors integrate aspects of physical pharmacy, biopharmaceuticals, drug delivery, and biotechnology. The book highlights the increased attention that the recent spectacular advances in dosage form design and drug delivery, gene therapy, and nanotechnology have brought to the field. See what’s new in the Second Edition: Additional author Ajit S. Narang brings an industrial practitioner perspective with increased focus on pharmacy math and statistics, and powders and granules Reorganized into the following three parts: Introduction, Physicochemical Principles, and Dosage Forms Chapters on...

  Opthalmic Drug Delivery System, Second Edition, Revised and Expanded
by Dekker


No description available

Topical and Transdermal Drug Delivery: Principles and Practice

Topical and Transdermal Drug Delivery: Principles and Practice
by Heather A. E. Benson (Editor), Adam C. Watkinson (Editor)


Practical drug development approaches presented by leading expertsDesigned to support the development of new, effective therapeutics, Topical and Transdermal Drug Delivery: Principles and Practice explains the principles underlying the field and then demonstrates how these principles are put into practice in the design and development of new drug products. Drawing together and reviewing the latest research findings, the book focuses on practical, tested, and proven approaches that are backed by industry case studies and the authors' firsthand experience. Moreover, the book emphasizes the mechanistic information that is essential for successful drug product development.Topical and Transdermal Drug Delivery: Principles and Practice is divided into two parts:Part One, Current Science, Skin...

Drug Delivery: Principles and Applications (Wiley Series in Drug Discovery and Development)

Drug Delivery: Principles and Applications (Wiley Series in Drug Discovery and Development)
by Binghe Wang (Author), Teruna J. Siahaan (Author), Richard A. Soltero (Author)


An indispensable tool for those working at the front lines of new drug development
Written for busy professionals at the forefront of new drug development, Drug Delivery gets readers quickly up to speed on both the principles and latest applications in the increasingly important field of drug delivery.
Recent developments in such areas as combinatorial chemistry, proteomics, and genomics have revolutionized researchers' ability to rapidly identify and synthesize new pharmacological compounds. However, delivery-related properties remain a significant reason for clinical trial failures.
Bringing together contributions by leading international experts, Drug Delivery covers the entire field in a systematic but concise way. It begins with an in-depth review of key fundamentals, such...

Protein Formulation and Delivery, Second Edition (Drugs and the Pharmaceutical Sciences)

Protein Formulation and Delivery, Second Edition (Drugs and the Pharmaceutical Sciences)
by Eugene J. McNally (Editor), Jayne E. Hastedt (Editor)


This title is intended to assist pharmaceutical scientists in the development of stable protein formulations during the early stages of the product development process, providing a comprehensive review of mechanisms and causes of protein instability in formulation development, coverage of accelerated stability testing methods and relevant analytical methods, and an overview of the drug substance manufacturing process. Preformulation and the development of traditional solutions and lyophilized formulations frequently used for intravenous delivery and non-traditional formulations are also addressed. Because many developments in the field have emerged since the publication of the First Edition, this Second Edition addresses important new patient-friendly developments in the field, such as...

  Drug Delivery Systems for Cardiovascular Diseases
by Shobha Rani R Hiremath (Editor), S. Narasimha Murthy (Editor)


Each year, more Americans die from heart diseases than cancer, yet there is no single source that combines information about cardiovascular diseases with disease-specific drug delivery systems. This book provides an overview of existing techniques, ongoing research, and novel approaches and concepts in the treatment of cardiovascular diseases by means of novel drug delivery systems. The text covers anatomy, biochemistry, pathophysiology, and pharmacotherapy. It also addresses problems associated with therapy, reasons for non-compliance, formulation and evaluation of drug delivery systems, as well as regulatory aspects of cardiovascular drug discovery systems.

Steroid Dimers: Chemistry and Applications in Drug Design and Delivery

Steroid Dimers: Chemistry and Applications in Drug Design and Delivery
by Satyajit Sarker (Author), Lutfun Nahar (Author)


Steroid dimers are an important group of compounds produced by various marine organisms, and also synthesized in the laboratories. This group of compounds possesses various pharmacological and biological properties, and can also be used to create  “molecular umbrellas” for drug delivery.Steroid Dimers: Chemistry and Applications in Drug Design and Delivery provides an up-to-date overview on the chemistry and applications of steroid dimers of natural and synthetic origins. The book includes easy-to-follow synthetic protocols for various classes of important dimeric steroids, source details, valuable spectroscopic data and depiction of unique structural features of natural steroidal dimers, and the Structure-Activity-Relationships (SARs) of some pharmacologically active dimeric...

corner bottom left corner bottom right
© 2012 BrightSurf.com